These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29400279)

  • 1. Keep bifurcation stenting simple and cheap or controlled and optimised?
    Holm NR; Andreasen LN; Christiansen EH
    EuroIntervention; 2018 Feb; 13(15):e1741-e1743. PubMed ID: 29400279
    [No Abstract]   [Full Text] [Related]  

  • 2. Bench testing and coronary artery bifurcations: a consensus document from the European Bifurcation Club.
    Ormiston JA; Kassab G; Finet G; Chatzizisis YS; Foin N; Mickley TJ; Chiastra C; Murasato Y; Hikichi Y; Wentzel JJ; Darremont O; Iwasaki K; Lefèvre T; Louvard Y; Beier S; Hojeibane H; Netravali A; Wooton J; Cowan B; Webster MW; Medrano-Gracia P; Stankovic G
    EuroIntervention; 2018 Feb; 13(15):e1794-e1803. PubMed ID: 29131803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Institutional Review of Percutaneous Coronary Intervention Appropriateness and the Effect on Quality of Care and Clinical Outcomes.
    Desai NR; Parzynski CS; Krumholz HM; Minges KE; Messenger JC; Nallamothu BK; Curtis JP
    JAMA Intern Med; 2015 Dec; 175(12):1988-90. PubMed ID: 26551259
    [No Abstract]   [Full Text] [Related]  

  • 5. Stenting: the Latest Frontier in Percutaneous Intervention.
    Kleiman N
    Methodist Debakey Cardiovasc J; 2018; 14(1):5-6. PubMed ID: 29623166
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II.
    Song YB; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Lee JH; Yu CW; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Oh JH; Park JS; Gwon HC
    JACC Cardiovasc Interv; 2014 Mar; 7(3):255-63. PubMed ID: 24529936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III Trial.
    Baron SJ; Lei Y; Chinnakondepalli K; Vilain K; Magnuson EA; Kereiakes DJ; Ellis SG; Stone GW; Cohen DJ;
    JACC Cardiovasc Interv; 2017 Apr; 10(8):774-782. PubMed ID: 28427593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Step-by-step manual for planning and performing bifurcation PCI: a resource-tailored approach.
    Milasinovic D; Wijns W; Ntsekhe M; Hellig F; Mohamed A; Stankovic G
    EuroIntervention; 2018 Feb; 13(15):e1804-e1811. PubMed ID: 29175768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approach to direct stenting using a novel "all-in-one" coronary stent system via 5 French diagnostic catheters: a pilot study.
    Khattab AA; O'Sullivan CJ; Stefanini GG; Räber L; Paquin M; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E403-10. PubMed ID: 23378279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial.
    Rodriguez AE; Rodriguez-Granillo AM; Antoniucci D; Mieres J; Fernandez-Pereira C; Rodriguez-Granillo GA; Santaera O; Rubilar B; Palacios IF; Serruys PW;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):385-94. PubMed ID: 22109997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One versus two stents: the cause or the effect?
    Colombo A; Chieffo A
    JACC Cardiovasc Interv; 2014 Mar; 7(3):264-5. PubMed ID: 24529930
    [No Abstract]   [Full Text] [Related]  

  • 12. Annual cost of stable coronary artery disease in France: A modeling study.
    Caruba T; Chevreul K; Zarca K; Cadier B; Juillière Y; Dubourg O; Sabatier B; Danchin N
    Arch Cardiovasc Dis; 2015 Nov; 108(11):576-88. PubMed ID: 26433733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Svelte integrated delivery system performance examined through diagnostic catheter delivery: the SPEED registry.
    Khattab AA; Nijhoff F; Schofer J; Berland J; Meier B; Nietlispach F; Agostoni P; Brucks S; Stella P
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E23-31. PubMed ID: 25130948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.
    Yates MT; Soppa GK; Valencia O; Jones S; Firoozi S; Jahangiri M
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):606-10. PubMed ID: 23402690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
    Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of significant left main coronary artery disease: A review.
    Akodad M; Morice MC
    Trends Cardiovasc Med; 2018 Jul; 28(5):357-364. PubMed ID: 29336945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club.
    Lassen JF; Burzotta F; Banning AP; Lefèvre T; Darremont O; Hildick-Smith D; Chieffo A; Pan M; Holm NR; Louvard Y; Stankovic G
    EuroIntervention; 2018 Jan; 13(13):1540-1553. PubMed ID: 29061550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of biodegradable polymer versus durable polymer drug-eluting stents incorporating real-world evidence.
    Teng M; Zhao YJ; Khoo AL; Ananthakrishna R; Yeo TC; Lim BP; Chan MY; Loh JP
    Cardiovasc Ther; 2018 Oct; 36(5):e12442. PubMed ID: 29873191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system.
    He Y; Zhang D; Yin D; Zhu C; Feng L; Song C; Chen C; Xu B; Dou K
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):591-598. PubMed ID: 29359406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of coronary bifurcation stenting strategy on health-related functional status: a quality-of-life analysis from the BBC One (British Bifurcation Coronary; Old, New, and Evolving Strategies) study.
    Sirker A; Sohal M; Oldroyd K; Curzen N; Stables R; de Belder A; Hildick-Smith D
    JACC Cardiovasc Interv; 2013 Feb; 6(2):139-45. PubMed ID: 23428004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.